As of now, Gennova's mRNA vaccine is still in the trial phase and has not yet received emergency use authorization from the Indian regulatory authorities. Therefore, the price of the booster dose is still unknown. However, some reports suggest that the vaccine could be priced at around Rs. 750-1,000 per dose. Once Gennova's mRNA vaccine receives approval, the government will decide on the price and availability of the vaccine. It is likely that the vaccine will be made available through government channels and sold at a subsidized price for the general public. The government has already announced that it aims to vaccinate the entire population by December 2021. Overall, the cost and availability of Gennova's mRNA vaccine booster dose in India will largely depend on the approval process and the government's decisions on distribution and pricing.